Related Experiment Videos
The effect of triamcinolone acetonide on the phagocytosis by human polymorphonuclear leukocytes
Abstract:
Using 3 H-thymidine-labeled bacteria, we investigated the phagocytosis by human polymorphonuclear leukocytes (PMN). PMN were isolated from 50 asthmatic and bronchitic patients treated with triamcinolone acetonide (TA). In general, the dose of TA was limited to 80 mg with an interval of 6 weeks or longer between AT injections. The phagocytosis of the Staphylococcus aureus Cowen-3 by the isolated PMN was inhibited. The strongest suppression of phagocytosis was observed on the 3rd day; after 14 days the phagocytic activity returned to normal.
Insights
Triamcinolone acetonide (TA) treatment temporarily suppressed the ability of human immune cells (polymorphonuclear leukocytes) to engulf bacteria, with effects normalizing within two weeks.
Area of Science:
- Immunology
- Pharmacology
Background:
- Phagocytosis is a critical immune process mediated by polymorphonuclear leukocytes (PMN).
- Asthma and bronchitis patients often receive corticosteroid treatments like triamcinolone acetonide (TA).
Purpose of the Study:
- To investigate the impact of triamcinolone acetonide (TA) on the phagocytic capacity of human PMN in patients with respiratory conditions.
- To quantify the effect of TA on Staphylococcus aureus engulfment by PMN.
Main Methods:
- Isolation of PMN from 50 asthmatic and bronchitic patients undergoing TA treatment.
- Utilizing 3H-thymidine-labeled Staphylococcus aureus Cowen-3 to assess bacterial phagocytosis by isolated PMN.
- Monitoring phagocytic activity at various time points post-TA treatment.
Main Results:
- Phagocytosis of Staphylococcus aureus by PMN was significantly inhibited in patients treated with TA.
- The strongest suppression of phagocytic activity was observed on the third day after TA administration.
- Phagocytic activity gradually recovered, returning to normal levels by day 14.
Conclusions:
- Triamcinolone acetonide (TA) demonstrates a transient inhibitory effect on PMN phagocytosis in patients with asthma and bronchitis.
- The observed immunosuppression is temporary, with immune function recovering within two weeks.
- These findings highlight the need to consider the impact of corticosteroid therapy on innate immune responses.